HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
453studies shown
Showing 49-60 of 453
Drug study icon
RecruitingNCT06191965

MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

This summary needs review. Please check the official study record and contact the research team for details.

In Belmont
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 35 Years
Countries
United States, Switzerland
Sponsor
Mclean Hospital
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT07098169

Study of iTEST: A Blended Intervention Targeting Introspective Accuracy

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including San Diego
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Other study type icon
RecruitingACTRN12617000086369

A combined PET-fMRI study of frontostriatal dysfunction in first episode psychosis

The registry describes this research topic: “A combined PET-fMRI study of frontostriatal dysfunction in first episode psychosis”. This is an observational study.

In Australia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 25 Years
Countries
Australia
Sponsor
Monash University
Condition
Schizophrenia
Drug study icon
RecruitingNCT07230652

Safety and Tolerability of LY03020

The registry lists this study as recruiting. Study locations are listed in China.

In Beijing
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
China
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Drug study icon
RecruitingNCT05995782

SAD and MAD Study Safety and Tolerability of FB418

The registry lists this study as recruiting. Study locations are listed in South Korea.

In Seoul
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 19 Years
Countries
South Korea
Sponsor
1ST Biotherapeutics, Inc.
Condition
Schizophrenia
Behavioral study icon
RecruitingACTRN12609000317291

A Control study of people with psychosis taking Risperdal Consta compared to people with psychosis taking Risperdal Consta and receiving Collaborative Therapy (a psychoeducational program) in a naturalistic setting

The registry lists this study as recruiting. Confirm recruitment at each site.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Sponsor
Prof. David Castle
Condition
Schizophrenia
Device study icon
RecruitingNCT07434479

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
Manhattan Psychiatric Center
Condition
Schizophrenia
Drug study icon
RecruitingNCT05316883

Biomarkers in Clozapine-responding Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Glostrup Municipality
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years
Countries
Denmark
Sponsor
Jimmi Nielsen
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.